Skip to content

Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer

Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07518888
Acronym
ESCAPE
Enrollment
49
Registered
2026-04-09
Start date
2026-08-01
Completion date
2028-08-01
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate Cancer, Exercise, Steroids

Brief summary

The purpose of this research study is to understand how a short session of a home-based bodyweight high-intensity interval training (HIIT) affects steroid hormone levels in men on active surveillance for low-grade prostate cancer.

Interventions

Participants will complete a single supervised, online high intensity interval training (HIIT) exercise session lasting approximately 20 minutes. The exercise protocol consists of six 1-minute bouts with 1-minute rest intervals of moderate to high intensity bodyweight exercises, including movements such as lateral squats, wall pushups, and chair assisted sit to stands.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Males 18 to 80 years old * Diagnosis of localized prostate cancer * Currently under active surveillance * Ability to perform moderate-to-high intensity physical activity as demonstrated by self-assessment using the Physical Activity Readiness Questionnaire (PAR-Q+) * Able to independently perform activities of daily living, without limitations in mobility * Ability to read, write, speak, and understand English * Able and willing to sign consent and comply with study requirements

Exclusion criteria

* Males currently receiving treatment for prostate cancer * Diagnosis of metastatic prostate cancer * Individuals with medical conditions contraindicating exercise * Uncontrolled cardiovascular or circulatory diseases, hypertension, and diabetes, as determined by the study doctor or treating physician * Ongoing use of medications affecting steroid metabolism * Unable to sign consent and/or comply with study requirements

Design outcomes

Primary

MeasureTime frameDescription
Protocol Completion RateFrom enrollment through completion of all study procedures (up to Day 1)Protocol Completion Rate is defined as the proportion of enrolled participants who complete both the supervised home-based HIIT exercise session and return all scheduled saliva samples to the laboratory.

Secondary

MeasureTime frameDescription
Acceptability of the Exercise and Saliva Collection ProtocolImmediately after protocol completion (Day 1)Acceptability will be assessed using a participant-reported questionnaire adapted from the Theoretical Framework of Acceptability (TFA). The questionnaire evaluates acceptability across seven domains: affective attitude, burden, perceived effectiveness, ethicality, intervention coherence, opportunity costs, and self-efficacy. Each domain is assessed using 1-2 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores are averaged, and an overall Acceptability Index score is calculated, with higher scores indicating greater acceptability.

Countries

United States

Contacts

CONTACTNima Sharifi, MD
nimasharifi@miami.edu305-243-1350
CONTACTElena Cortizas, MS
ecortizas@med.miami.edu(305) 243-3593
PRINCIPAL_INVESTIGATORNima Sharifi, MD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026